乳腺癌易感基因环状结构域蛋白抗体Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BRCA1 Associated RING Domain gene 1 (BARD1) interacts with the N terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, BARD1 shares homology with the 2 most conserved regions of BRCA1:乳腺癌易感基因环状结构域蛋白抗体Q the N terminal RING motif and the C terminal BRCT domain. The RING motif is a cysteine rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. The BARD1 protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression.乳腺癌易感基因环状结构域蛋白抗体Q BARD1 may be the target of oncogenic mutations in breast or ovarian cancer. BARD1 also plays a role in mediating apoptotic stress and p53 dependent.
Also known as:
BARD-1; Bard1; Bard 1; BARD1_HUMAN; BRCA1 associated RING domain 1; BRCA1 associated RING domain gene 1;乳腺癌易感基因环状结构域蛋白抗体Q BRCA1 associated RING domain protein 1; BRCA1-associated RING domain protein 1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BARD1.
●
乳腺癌易感基因环状结构域蛋白抗体QPredicted Molecular Weight: 85kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl014Po01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Rb53骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl015Hu01骨成型蛋白受体1A(BMPR1A)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl015Mu01骨成型蛋白受体1A(BMPR1A)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl015Ra01骨成型蛋白受体1A(BMPR1A)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl017Bo01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Ga01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Hu01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Mu01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Po01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Ra01上皮性钙黏附蛋白(CDHE)多克隆抗体Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl019Hu01白介素8受体α(IL8Rα)多克隆抗体Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
kl019Mu01白介素8受体α(IL8Rα)多克隆抗体Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
kl019Ra01白介素8受体α(IL8Rα)多克隆抗体Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
kl019Rb51白介素8受体α(IL8Rα)多克隆抗体Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
kl021Ga01睫状神经营养因子(CNTF)多克隆抗体Polyclonal Antibody to Ciliary Neurotrophic Factor (CNTF)
kl021Hu01睫状神经营养因子(CNTF)多克隆抗体Polyclonal Antibody to Ciliary Neurotrophic Factor (CNTF)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话